APA

Oubrie A., Kaptein A., de Zwart E., Hoogenboom N., Goorden R., van de Kar B., van Hoek M., de Kimpe V., van der Heijden R., Borsboom J., Kazemier B., de Roos J., Scheffers M., Lommerse J., Schultz-Fademrecht C. & Barf T. (20120803). Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. : Bioorganic & medicinal chemistry letters.

Chicago

Oubrie Arthur, Kaptein Allard, de Zwart Edwin, Hoogenboom Niels, Goorden Rianne, van de Kar Bas, van Hoek Maaike, de Kimpe Vera, van der Heijden Ruud, Borsboom Judith, Kazemier Bert, de Roos Jeroen, Scheffers Michiel, Lommerse Jos, Schultz-Fademrecht Carsten and Barf Tjeerd. 20120803. Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. : Bioorganic & medicinal chemistry letters.

Harvard

Oubrie A., Kaptein A., de Zwart E., Hoogenboom N., Goorden R., van de Kar B., van Hoek M., de Kimpe V., van der Heijden R., Borsboom J., Kazemier B., de Roos J., Scheffers M., Lommerse J., Schultz-Fademrecht C. and Barf T. (20120803). Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. : Bioorganic & medicinal chemistry letters.

MLA

Oubrie Arthur, Kaptein Allard, de Zwart Edwin, Hoogenboom Niels, Goorden Rianne, van de Kar Bas, van Hoek Maaike, de Kimpe Vera, van der Heijden Ruud, Borsboom Judith, Kazemier Bert, de Roos Jeroen, Scheffers Michiel, Lommerse Jos, Schultz-Fademrecht Carsten and Barf Tjeerd. Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series. : Bioorganic & medicinal chemistry letters. 20120803.